This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Brook RA, Wahlqvist P, Kleinman NL, Wallander M-A, Campbell SM, Smeeding JE.Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Alimentary Pharmacology and Therapeutics 26: 889-898, No. 6, 15 Sep 2007
Rights and permissions
About this article
Cite this article
GORD costly to US employers. Pharmacoecon. Outcomes News 540, 13 (2007). https://doi.org/10.2165/00151234-200705400-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705400-00026